J&J to Pay $5.9 Million Risperdal Penalty

Montana Rules J&J Subsidiaries to Pay Millions for Risperdal Marketing A subsidiary of Johnson & Johnson has agreed to pay $5.9 million after a Montana court ruled that Risperdal was marketed off-label. The settlement claims that Janssen Pharmaceuticals, Risperdal’s manufacturers, marketed Risperdal for inappropriate uses in children and … [Read more...]

J&J Begins Risperdal Fight in Arkansas

Johnson & Johnson Begins Fight Against $1.2 Billion Risperdal Judgment in Arkansas Last month, Johnson & Johnson filed appeals in various states which had ruled to penalize the pharmaceutical giant for off-label marketing of its antipsychotic drug, Risperdal. On Thursday, February 27th, the appeals process in Arkansas began, with J&J … [Read more...]

J&J Negligent in Talcum Powder Lawsuit

Jury Rules J&J Was Negligent with Talcum Powder, but Pays No Penalty In November 2013, a South Dakota jury ruled that pharmaceutical giant Johnson & Johnson was guilty of negligence involving their talcum powder product, Shower to Shower, but that they would pay no financial penalty for failure to warn. Deane Berg, 56, was diagnosed with … [Read more...]

Study Connects Talcum Powder and Ovarian Cancer

New Study Shows Link Between Talcum Powder Use and Ovarian Cancer Risk A new study published in November 2013, conducted by Brigham and Women’s Hospital in Boston, showed that regular talcum powder use can be linked to a higher risk of developing ovarian cancer. Talcum powder is a substance used often in cosmetics and body powders, and is derived … [Read more...]

Johnson & Johnson Successfully Appeals Risperdal Penalty

Louisiana Court Overturns $258 Million Penalty Against J&J for Risperdal Marketing On Tuesday, January 28th, pharmaceutical giant Johnson & Johnson won an appeal in Louisiana Supreme Court to overturn a $258 million penalty for marketing practices associated with its antipsychotic drug, Risperdal. The ruling stated that Louisiana Attorney … [Read more...]

Johnson & Johnson to Appeal Risperdal Fine

J&J and Janssen Pharmaceuticals to Appeal Arkansas’s Risperdal Fine In April 2012, jurors in Arkansas agreed that Johnson & Johnson, and its subsidiary Janssen Pharmaceuticals, misled Arkansas’s doctors and patients about the risks of the anti-psychotic drug, Risperdal. Now, J&J has filed to appeal that ruling, and oral arguments … [Read more...]

J&J Agree to $2.5 Billion Settlement for DePuy ASR Personal Injury Cases

Settlement Negotiations Finally Land on $2.5 Billion Payment to Victims of J&J’s DePuy ASR Hip Replacement Device After much back and forth, pharmaceutical manufacturer Johnson & Johnson has finally agreed to pay $2.5 billion to settle personal injury claims involving its all-metal hip replacement device, the DePuy ASR. J&J, its … [Read more...]

J&J Settles DePuy ASR Personal Injury Cases for $4 Billion

J&J Finalizes Largest Medical Device Settlement in US History for DePuy ASR Hip Replacement Devices On Tuesday, November 12th, Johnson & Johnson finalized the largest medical device settlement agreement in US history. The pharmaceutical company and their subsidiary, DePuy, agreed to pay $4 billion to settle thousands of personal injury … [Read more...]

Johnson & Johnson to Pay Settlement for Risperdal Personal Injury

J&J Announces Settlement Payments for US Probes into Risperdal Personal Injury On Monday, November 4th, Johnson & Johnson announced that they would pay $2 billion to settle US government civil and criminal probes into personal injury caused by their antipsychotic drug, Risperdal. Reportedly, the blockbuster pharmaceutical manufacturer … [Read more...]

Risperdal Personal Injury Lawsuits Growing in Number

Johnson & Johnson Faces Numerous, Serious Personal Injury Lawsuits Due to Taking Risperdal In September, Johnson & Johnson issued a recall notice for Risperdal Consta, a long-acting form of the anti-psychotic drug, Risperdal. At the time, the pharmaceutical manufacturer believed that there were no injuries as a result of taking the … [Read more...]

BestLawyers.comAVBetter Business Bureau